Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Injections × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 22 Myelodysplastic Syndromes 6 Leukemia, Myelomonocytic, Chronic 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Advanced Solid Tumors 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Lung Neoplasms 4 Advanced Solid Tumour 4 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Myeloproliferative Disorders 3 Multiple Myeloma 3 Breast Neoplasms 3 Biliary Tract Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 Advanced Malignant Solid Tumor 2 mCRPC (Metastatic Castration-resistant Prostate Cancer) 1 Uterine Cervical Neoplasms 1 Unresectable Locally Recurrent Breast Cancer 1 Tuberous Sclerosis 1

Interventions

Carboplatin 5 Specimen Handling 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 pembrolizumab 3 Radiotherapy 3 Radiation 3 Pemetrexed 3 Biopsy 3 Bevacizumab 3 fludarabine phosphate 2 Taxes 2 Radiosurgery 2 Platinum 2 Paclitaxel 2 Mastectomy, Segmental 2 Ipilimumab 2 Cyclophosphamide 2 CTLA-4 Antigen 2 Anterior Temporal Lobectomy 2 veliparib 1 methoxyamine 1 fludarabine 1 durvalumab 1 defactinib 1 dapagliflozin 1 capmatinib 1 bemarituzumab 1 atezolizumab 1 aldesleukin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡